AGP Executive Report
Last update: 4 hours agoMedical Tech: Vanderbilt researchers report that a mobile intraoperative PET-CT can map scattered residual head-and-neck tumors after chemoimmunotherapy, aiming to sharpen margin decisions. Neuroimmune Biotech: ChronicleBio names immunology veteran John Mumm as CSO to push multi-omics/AI drug discovery for ME/CFS, Long COVID, and POTS. Immunology/Oncology Leadership: Harbour BioMed appoints Luisa Salter-Cid as Scientific Advisor; Viking Therapeutics brings in Hubert Chen as Chief Medical Officer. Public Health & Policy: Rhode Island confirms a new Cannabis Control Commission chair, while the U.S. intelligence nomination of Jay Clayton spotlights shifting oversight priorities. Climate & Risk: NOAA says El Niño is forming and could hit historic strength, raising odds of extreme heat, floods, droughts, and fires. Health & Lifestyle: A large study backs combining aerobic exercise with resistance training for lower mortality risk. Veterinary Innovation: Pelara launches first U.S. veterinary clinical trials of low-intensity focused ultrasound for chronic pain. Business/Techbio Finance: UniUni files for a Canadian public listing as it scales last-mile delivery.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
